In an interview with British Medical Journal, Pfizer clinical trial whistleblower Brook Jackson described mislabeled specimens, unblinded participants, and ignored safety concerns at Ventavia Research Group. 

After reporting the issues to the U.S. Food and Drug Administration, she says she was fired within six hours.

Regional director reported mislabeled samples, unblinded participants, and ignored safety concerns, then was terminated the same day.

LINK TO DETAILS: https://open.substack.com/pub/lionessofjudah/p/important-reminder-pfizer-whistleblower?r=1dbkwf&utm_medium=ios